Steeb, Theresa
Heppt, Markus V.
Becker, Lars
Kohl, Christoph
French, Lars E.
Berking, Carola https://orcid.org/0000-0003-0229-8931
Funding for this research was provided by:
Deutsche Krebshilfe (70112351)
Article History
Received: 8 June 2019
Accepted: 10 September 2019
First Online: 11 October 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: CB has been a member of advisory boards for Almirall Hermal, Biofrontera, Galderma, ISDIN, and Leo Pharma. CB has received speaker“s honoraria by Almirall Hermal, Galderma, and Leo Pharma. CB has received funding for clinical research by Leo Pharma. The remaining authors declare that they have no competing interests.